CA2141704A1 - Solutions aqueuses concentrees d'argatroban - Google Patents
Solutions aqueuses concentrees d'argatrobanInfo
- Publication number
- CA2141704A1 CA2141704A1 CA002141704A CA2141704A CA2141704A1 CA 2141704 A1 CA2141704 A1 CA 2141704A1 CA 002141704 A CA002141704 A CA 002141704A CA 2141704 A CA2141704 A CA 2141704A CA 2141704 A1 CA2141704 A1 CA 2141704A1
- Authority
- CA
- Canada
- Prior art keywords
- concentrated aqueous
- argatroban
- esp
- solutions
- argatroban solutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Luminescent Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Solutions aqueuses concentrées d'argatroban contenant de l'argatroban, un agent formateur de micelles et une substance lipoïde.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9401195A FR2715566B1 (fr) | 1994-02-03 | 1994-02-03 | Solutions aqueuses concentrées d'argatroban. |
FR94.01195 | 1994-02-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2141704A1 true CA2141704A1 (fr) | 1995-08-04 |
CA2141704C CA2141704C (fr) | 2001-07-03 |
Family
ID=9459714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002141704A Expired - Lifetime CA2141704C (fr) | 1994-02-03 | 1995-02-02 | Solutions aqueuses concentrees d'argatroban |
Country Status (25)
Country | Link |
---|---|
US (1) | US5679690A (fr) |
EP (1) | EP0669131B1 (fr) |
JP (1) | JP3027103B2 (fr) |
KR (1) | KR100257692B1 (fr) |
CN (1) | CN1054743C (fr) |
AT (1) | ATE179327T1 (fr) |
AU (1) | AU687133B2 (fr) |
CA (1) | CA2141704C (fr) |
CZ (1) | CZ284611B6 (fr) |
DE (1) | DE69509279T2 (fr) |
DK (1) | DK0669131T3 (fr) |
ES (1) | ES2132547T3 (fr) |
FI (1) | FI950459A (fr) |
FR (1) | FR2715566B1 (fr) |
GR (1) | GR3030149T3 (fr) |
HK (1) | HK1013623A1 (fr) |
HU (1) | HU218220B (fr) |
IL (1) | IL112527A (fr) |
NO (1) | NO307324B1 (fr) |
NZ (1) | NZ270445A (fr) |
PL (1) | PL178586B1 (fr) |
RU (1) | RU2136282C1 (fr) |
SK (1) | SK12795A3 (fr) |
TW (1) | TW436295B (fr) |
ZA (1) | ZA95837B (fr) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840733A (en) * | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
US5786153A (en) * | 1996-09-12 | 1998-07-28 | Chiron Diagnostics Corporation | Prevention of probe coating on automated analyzers using a non-denaturing surfactant |
CA2291735A1 (fr) * | 1997-05-27 | 1998-12-03 | Takahiro Ogawa | Preparations aqueuses contenant de l'israpafant |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
FR2793412B1 (fr) * | 1999-05-11 | 2001-07-27 | Synthelabo | Formulations galeniques d'argatroban pour administration sous-cutanee |
KR100399373B1 (ko) * | 2000-12-20 | 2003-09-26 | 주식회사 아이센스 | 콜란산 고리를 포함하는 디글라이콜릭 디아마이드 유도체,그의 제조방법 및 용도 |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
WO2002078512A2 (fr) | 2001-04-02 | 2002-10-10 | Therasense, Inc. | Dispositif et procede de recherche de glucose dans le sang |
US6984395B2 (en) * | 2001-04-11 | 2006-01-10 | Qlt, Inc. | Drug delivery system for hydrophobic drugs |
AU2003303597A1 (en) | 2002-12-31 | 2004-07-29 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
JP3781308B2 (ja) * | 2003-03-20 | 2006-05-31 | 三菱ウェルファーマ株式会社 | アルギニンアミド類を含有する医薬製剤 |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
EP1718198A4 (fr) | 2004-02-17 | 2008-06-04 | Therasense Inc | Procede et systeme de communication de donnees dans un systeme de controle et de gestion de glucose en continu |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
CN102895179B (zh) * | 2005-09-01 | 2014-10-22 | 巴克斯特国际公司 | 含有酸作为增溶剂的阿加曲班制剂 |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
US8895777B2 (en) * | 2006-08-31 | 2014-11-25 | Emisphere Technologies Inc | Compounds and compositions for delivering active agents |
US7687516B2 (en) * | 2006-09-27 | 2010-03-30 | Eagle Pharmaceuticals, Inc. | Alcohol free formulation of argatroban |
CA2669727C (fr) * | 2006-09-27 | 2014-10-28 | Eagle Pharmaceuticals, Inc. | Preparation sans alcool d'argatropan |
US20100076019A1 (en) * | 2006-10-11 | 2010-03-25 | Eagle Pharmaceuticals, Inc. | Alcohol free formulation of argatroban |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
WO2008135828A2 (fr) | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticules comprenant un médicament, de l'éthylcellulose et un sel biliaire |
WO2008135855A2 (fr) | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticules contenant un inhibiteur de la protéine de transfert d'ester de cholestéryle et un polymère non ionisable |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8974827B2 (en) | 2007-06-04 | 2015-03-10 | Bend Research, Inc. | Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
US9545384B2 (en) | 2007-06-04 | 2017-01-17 | Bend Research, Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate |
WO2009073215A1 (fr) | 2007-12-06 | 2009-06-11 | Bend Research, Inc. | Compositions pharmaceutiques comprenant des nanoparticules et une matière de remise en suspension |
US9233078B2 (en) | 2007-12-06 | 2016-01-12 | Bend Research, Inc. | Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer |
US20090221637A1 (en) * | 2008-02-29 | 2009-09-03 | Baxter International Inc. | Solid-state salt argatroban formulations and methods for producing and using the same |
US7915290B2 (en) * | 2008-02-29 | 2011-03-29 | Baxter International Inc. | Argatroban formulations and methods for making and using same |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
WO2010127050A1 (fr) | 2009-04-28 | 2010-11-04 | Abbott Diabetes Care Inc. | Détection d'erreur dans des données de répétition critiques dans un système de capteur sans fil |
WO2010138856A1 (fr) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Systèmes d'antenne de dispositif médical comportant des configurations d'antenne externe |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
EP2482720A4 (fr) | 2009-09-29 | 2014-04-23 | Abbott Diabetes Care Inc | Procédé et appareil de fourniture de fonction de notification dans des systèmes de surveillance de substance à analyser |
CN102366410B (zh) * | 2011-09-14 | 2013-05-29 | 海南灵康制药有限公司 | 一种阿加曲班脂质体注射剂 |
EP2775918B1 (fr) | 2011-11-07 | 2020-02-12 | Abbott Diabetes Care Inc. | Dispositif et procédés de contrôle de substance à analyser |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US20150034098A1 (en) | 2013-07-11 | 2015-02-05 | Aqua Turf International, Inc. | Air filtration mask with opening front cover |
DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
CN114025746B (zh) * | 2019-05-10 | 2023-08-25 | 福多兹制药公司 | 抗血栓形成剂的可注射聚合物纳米颗粒组合物及其方法 |
CN110478471B (zh) * | 2019-09-17 | 2020-04-10 | 鲁南制药集团股份有限公司 | 一种阿加曲班注射液及其制备方法 |
US20230134153A1 (en) | 2020-07-03 | 2023-05-04 | Toshiba Mitsubishi-Electric Industrial Systems Corporation | Uninterruptible power supply system |
EP4070658A1 (fr) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Utilisation de composés anticoagulants comme rodenticides |
CN113855635A (zh) * | 2021-10-20 | 2021-12-31 | 陇南市第一人民医院 | 一种阿加曲班注射液脂质体及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE48623B1 (en) * | 1978-08-31 | 1985-03-20 | Mitsubishi Chem Ind | Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances |
JPS6431727A (en) * | 1987-07-28 | 1989-02-02 | Mitsubishi Chem Ind | Dissolution of argininamide and drug composition containing argininamides |
JPH02129123A (ja) * | 1988-11-07 | 1990-05-17 | Mitsubishi Kasei Corp | 抗血液凝固剤 |
CA2091715A1 (fr) * | 1992-03-18 | 1993-09-19 | Mitsubishi Kasei Corporation | Preparations d'argatroban pour usage ophtalmique |
EP0566897A3 (en) * | 1992-04-07 | 1994-07-06 | Hoechst Ag | The complete gene (cefg) encoding the acetyl-coa: deacetylcephalosporin c acetyltransferase of cephalosporium acremonium, its isolation and use |
-
1994
- 1994-02-03 FR FR9401195A patent/FR2715566B1/fr not_active Expired - Fee Related
-
1995
- 1995-01-21 TW TW084100521A patent/TW436295B/zh active
- 1995-01-28 CN CN95101782A patent/CN1054743C/zh not_active Expired - Fee Related
- 1995-02-02 NO NO950377A patent/NO307324B1/no unknown
- 1995-02-02 FI FI950459A patent/FI950459A/fi unknown
- 1995-02-02 KR KR1019950001836A patent/KR100257692B1/ko not_active IP Right Cessation
- 1995-02-02 IL IL11252795A patent/IL112527A/xx not_active IP Right Cessation
- 1995-02-02 DE DE69509279T patent/DE69509279T2/de not_active Expired - Fee Related
- 1995-02-02 SK SK127-95A patent/SK12795A3/sk unknown
- 1995-02-02 CZ CZ95271A patent/CZ284611B6/cs not_active IP Right Cessation
- 1995-02-02 AT AT95400214T patent/ATE179327T1/de not_active IP Right Cessation
- 1995-02-02 PL PL95307041A patent/PL178586B1/pl unknown
- 1995-02-02 ZA ZA95837A patent/ZA95837B/xx unknown
- 1995-02-02 AU AU11543/95A patent/AU687133B2/en not_active Ceased
- 1995-02-02 JP JP7015900A patent/JP3027103B2/ja not_active Expired - Lifetime
- 1995-02-02 CA CA002141704A patent/CA2141704C/fr not_active Expired - Lifetime
- 1995-02-02 DK DK95400214T patent/DK0669131T3/da active
- 1995-02-02 ES ES95400214T patent/ES2132547T3/es not_active Expired - Lifetime
- 1995-02-02 RU RU95101387A patent/RU2136282C1/ru active
- 1995-02-02 EP EP95400214A patent/EP0669131B1/fr not_active Expired - Lifetime
- 1995-02-02 HU HU9500308A patent/HU218220B/hu not_active IP Right Cessation
- 1995-02-02 US US08/382,791 patent/US5679690A/en not_active Expired - Lifetime
- 1995-02-02 NZ NZ270445A patent/NZ270445A/en unknown
-
1998
- 1998-12-23 HK HK98114973A patent/HK1013623A1/xx not_active IP Right Cessation
-
1999
- 1999-05-06 GR GR990401237T patent/GR3030149T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU687133B2 (en) | Concentrated aqueous solutions of argatroban | |
NZ278072A (en) | Phenylacetic acid oxime derivatives; biocides | |
AU589176B2 (en) | New tetrapyrrole therapeutic agents | |
MY113733A (en) | Salts of an anti-migraine indole derivative | |
AU5162796A (en) | Novel peptide derivatives | |
NZ296479A (en) | Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp) | |
AU6893994A (en) | Pharmaceutical compositions | |
PL308203A1 (en) | Synthesis of n-acetloneuraminic acid derivatives | |
AU6290296A (en) | Preparation of bicyclohexane derivative | |
AU7335598A (en) | A process for the preparation of 1,4,7,10-tetraazacyclododecane | |
TW334437B (en) | Process for the preparation of streptogramins | |
AP9400608A0 (en) | "New nicotinic acid derivative". | |
TW346490B (en) | Antiparasitic agents | |
CA2183808A1 (fr) | Retroviseur et methode d'assemblage connexe | |
HUP9904595A2 (hu) | Továbbfejlesztett diagnosztikai és terápiás készítmények | |
DE69508496T2 (de) | Endothelin-antagonisierendes Peptid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20150202 |